FDA
Top 50 pharmaceutical blogs and publications
May 10 by Leila HawkinsPharma IQ rounds up the best online resources for pharmaceutical professionals in 2022
Keeping tabs on pharma: UK hails “major step forward” in treating schizophrenia
February 08 by Leila HawkinsUK approves first long-acting new treatment for schizophrenia, Venus Remedies joins coalition to tackle anti-microbial resistance (AMR) and FDA resumes medical device inspections as Covid rates drop
Keeping tabs on pharma: FDA fast tracks Novartis osteoarthritis drug and grants approval for Janssen’s long-acting schizophrenia drug
September 03 by Adam JeffsPharma IQ dives into the latest updates from the FDA for new drugs that have been developed by Novartis and Janssen
Keeping tabs on Covid-19: EMA approves Moderna vaccine for teens and Japan approves Roche–Regeneron’s treatment
July 30 by Emily UwemedimoThe EMA recommends Moderna’s Covid-19 vaccine for 12–17 year olds as discussions continue with the FDA for approval for children in the US
FDA grants accelerated approval for first Alzheimer’s disease treatment
June 11 by Emily UwemedimoThe FDA has approved Biogen and Eisai’s Alzheimer’s disease drug aducanumab
Keeping tabs on pharma: Covid-19 vaccine trials for children aged five to 11 proving effective and Oxford malaria vaccine commended for WHO-breakthrough
May 21 by Emily UwemedimoOxford malaria vaccine achieves high-level efficacy of 77 per cent in African children overcoming WHO’s specified efficacy goal of 75 per cent
Keeping tabs on pharma: Pfizer aims for clinical trial diversity and EMA urges public to be aware of falsified medicines in face of Covid-19 pandemic
May 07 by Emily UwemedimoPfizer’s latest TV ad encourages underrepresented groups to consider participating in clinical trials
A regulatory perspective on real-world data and real-world evidence
April 23 by Sanyam GandhiDive into the thoughts and insights of a regulatory expert at Takeda as he evaluates how two data solutions can support drug development study requirements
Keeping tabs on Covid-19: AstraZeneca hoping to win US approval for their Covid-19 vaccine and J&J resumes its vaccine roll out in Europe
April 23 by Emily UwemedimoWith global demand for the Covid-19 vaccine still uncertain, two big pharma companies look to enhance their vaccination roll out programs in Europe and the US
Evaluating the use of AnIML as a data format to increase laboratory efficiency
March 23 by Pharma IQLearn how to standardize data for laboratory use, no matter what instruments or measurement techniques are used in the development process
Keeping tabs on Covid-19: GAO addresses concerns over FDA backlog and pharma discovers crucial jigsaw piece to help fight coronavirus
March 05 by Emily UwemedimoUK diagnostics submits emergency use authorization request for T cell immune response test
Keeping tabs on pharma: Johnson & Johnson’s single-dose vaccine is 72 percent effective and the global antibiotics market set to increase in value
February 26 by Emily UwemedimoThe FDA has authorized Johnson & Johnson's Covid-19 vaccine for emergency use, a critical step in bringing a third shot to the US